Mary Eapen, MRCPI, MS, MBBS

Professor

view physician profile

Locations

Froedtert Hospital
Cancer Center - Froedtert Hospital

Specialties

Hematology
Medical Oncology

Languages

English

Education

MRCPI - Gen Med Royal College of Phy of Ireland
MS -Master of Science
MBBS - Doctor of Medicine

Biography

Dr. Eapen received her MBBS from Ahmadu Bello University, Zaria, Nigeria, in 1987. She completed a pediatric residency in 1997. In 2000, Dr. Eapen completed a fellowship in hematology/oncology/blood and bone marrow transplant and a MS in Clinical Research at the University of Minnesota, Minneapolis, Minnesota.

Research Interests

Mary Eapen, MD, MS, is Professor at the Medical College of Wisconsin and Senior Scientific Director - Research, Center for International Blood and Marrow Transplant Research. Her research focuses on the use of graft sources other than bone marrow for allogeneic hematopoietic cell transplantation for acute leukemia and marrow failure disorders.

The Effect of Granulocyte Colony-Stimulating Factor Use on Hospital Length of Stay after Allogeneic Hematopoietic Cell Transplantation: A Retrospective Multicenter Cohort Study.

(George G, Martin AS, Chhabra S, Eapen M.) Biol Blood Marrow Transplant. 2020 Dec;26(12):2359-2364 PMID: 32818554 PMCID: PMC7686090 SCOPUS ID: 2-s2.0-85091241149 08/21/2020
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.

(Qayed M, Ahn KW, Kitko CL, Johnson MH, Shah NN, Dvorak CC, Mellgren KM, Friend BD, Verneris MR, Leung W, Toporski J, Levine JE, Chewning JH, Wayne AS, Kapoor U, Triplett BM, Schultz KR, Yanik GA, Eapen M.) Blood. 2020 11 18 PMID: 33206937 11/19/2020
Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome.

(Wolska-Kusnierz B, Pastorczak A, Fendler W, Wakulinska A, Dembowska-Baginska B, Heropolitanska-Pliszka E, Piatosa B, Pietrucha B, Kalwak K, Ussowicz M, Pieczonka A, Drabko K, Lejman M, Koltan S, Gozdzik J, Styczynski J, Fedorova A, Miakova N, Deripapa E, Kostyuchenko L, Krenova Z, Hlavackova E, Gennery A, Sykora KW, Ghosh S, Albert MH, Balashov D, Eapen M, Svec P, Seidel MG, Kilic SS, Tomaszewska A, Wiesik-Szewczyk E, Kreins A, Greil J, Buechner J, Lund B, Gregorek H, Chrzanowska K, Mlynarski W.) Clin Cancer Res. 2020 Oct 20 PMID: 33082212 10/22/2020
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.

(Solomon SR, Martin AS, Zhang MJ, Ballen K, Bashey A, Battiwalla M, Baxter-Lowe LA, Brunstein C, Chhabra S, Perez MAD, Fuchs EJ, Ganguly S, Hardy N, Hematti P, McGuirk J, Peres E, Ringden O, Rizzieri D, Romee R, Solh M, Szwajcer D, van der Poel M, Waller E, William BM, Eapen M.) Biol Blood Marrow Transplant. 2020 Oct;26(10):1930-1936 PMID: 32649981 PMCID: PMC7530013 SCOPUS ID: 2-s2.0-85089075393 07/11/2020
Double unrelated umbilical cord blood versus HLA-haploidentical bone marrow transplantation (BMT CTN 1101).

(Fuchs EJ, O'Donnell PV, Eapen M, Logan BR, Antin JH, Dawson P, Devine SM, Horowitz MM, Horwitz ME, Karanes C, Leifer E, Magenau JM, McGuirk JP, Morris LE, Rezvani AR, Jones RJ, Brunstein CG.) Blood. 2020 Aug 31 PMID: 32870242 09/02/2020
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.

(D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM.) Biol Blood Marrow Transplant. 2020 Aug;26(8):e177-e182 PMID: 32438042 PMCID: PMC7404814 SCOPUS ID: 2-s2.0-85085969206 05/22/2020
Hematopoietic Stem Cell Transplantation for Shwachman-Diamond Syndrome.

(Myers K, Hebert K, Antin J, Boulad F, Burroughs L, Hofmann I, Kamble R, MacMillan ML, Eapen M.) Biol Blood Marrow Transplant. 2020 Aug;26(8):1446-1451 PMID: 32428734 PMCID: PMC7371524 SCOPUS ID: 2-s2.0-85086565275 05/20/2020
Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.

(Brazauskas R, Scigliuolo GM, Wang HL, Cappelli B, Ruggeri A, Fitzhugh CD, Hankins JS, Kanter J, Meerpohl JJ, Panepinto JA, Rondelli D, Shenoy S, Walters MC, Wagner JE, Tisdale JF, Gluckman E, Eapen M.) Blood. 2020 Jul 30;136(5):623-626 PMID: 32518950 PMCID: PMC7393258 SCOPUS ID: 2-s2.0-85089126120 06/11/2020
Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia.

(Eapen M, Zhang MJ, Tang XY, Lee SJ, Fei MW, Wang HL, Hebert KM, Arora M, Chhabra S, Devine SM, Hamadani M, D'Souza A, Pasquini MC, Phelan R, Rizzo JD, Saber W, Shaw BE, Weisdorf DJ, Horowitz MM.) Biol Blood Marrow Transplant. 2020 07;26(7):e161-e166 PMID: 32389803 PMCID: PMC7206419 SCOPUS ID: 2-s2.0-85084668943 05/12/2020
Comparison of total body irradiation versus non- total body irradiation containing regimens for de novo acute myeloid leukemia in children.

(Dandoy CE, Davies SM, Ahn KW, He Y, Kolb AE, Levine J, Bo-Subait S, Abdel-Azim H, Bhatt N, Chewing J, Gadalla S, Gloude N, Hayashi R, Lalefar NR, Law J, MacMillan M, O'Brien T, Prestidge T, Sharma A, Shaw P, Winestone L, Eapen M.) Haematologica. 2020 Jun 18 PMID: 32554562 SCOPUS ID: 2-s2.0-85086742043 06/20/2020
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.

(Fatobene G, Rocha V, St Martin A, Hamadani M, Robinson S, Bashey A, Boumendil A, Brunstein C, Castagna L, Dominietto A, Finel H, Chalandon Y, Kenzey C, Kharfan-Dabaja M, Labussière-Wallet H, Moraleda JM, Pastano R, Perales MA, El Ayoubi HR, Ruggeri A, Sureda A, Volt F, Yakoub-Agha I, Zhang MJ, Gluckman E, Montoto S, Eapen M.) J Clin Oncol. 2020 May 10;38(14):1518-1526 PMID: 32031876 PMCID: PMC7213591 SCOPUS ID: 2-s2.0-85084380128 02/08/2020
A resurgence of cord blood transplantation?

(Eapen M.) Lancet Haematol. 2020 02;7(2):e89-e90 PMID: 31704263 SCOPUS ID: 2-s2.0-85078869834 11/11/2019